M. Fuller et al., RECEPTOR-MEDIATED BINDING OF 2 GLYCOSYLATION FORMS OF N-ACETYLGALACTOSAMINE-4-SULFATASE, Biochimica et biophysica acta. Molecular basis of disease, 1406(3), 1998, pp. 283-290
The lysosomal storage disorders are a group of inherited metabolic dis
eases each characterised by a relative or absolute deficiency of one o
r more of the lysosomal proteins involved in the hydrolysis of glycoco
njugates or in the transport of the resulting product. Enzyme replacem
ent therapies are under consideration for a number of these disorders
and are based on the in vitro observation that cells from affected pat
ients can be corrected by addition of exogenous enzyme. In this study,
two glycosylation variants of the lysosomal enzyme N-acetylgalactosam
ine-4-sulphatase (45) (the deficiency of which causes Mucopolysacchari
dosis (MPS) type VI, (Maroteaux-Lamy syndrome) were made by expression
of 45 cDNA in both wild type chinese hamster ovary (CHO-K1), and Led
(N-acetylglucosaminyltransferase I deficient CHO-K1) cells. Difference
s in the glycosylation pattern of the two enzyme forms were demonstrat
ed with endoglycosidase H and N-glycosidase F digestions. The receptor
mediated binding of these two forms of 45 to two cell types, human sk
in fibroblasts and rat alveolar macrophages, was then analysed. We hav
e shown that both enzyme forms bind to the mannose-6-phosphate recepto
r on human skin fibroblasts with equal affinity demonstrating that the
degree of phosphorylation of mannose residues in the two forms is sim
ilar. However, using rat alveolar macrophages, we found that the bindi
ng/uptake of the two enzymes differs considerably. These results show
that differences in glycosylation of lysosomal enzymes can be an impor
tant factor in altering enzyme uptake by different cell types. Thus, p
roducing carbohydrate modification variants in this way may be useful
for altering the distribution of exogenous enzyme in vivo. (C) 1998 El
sevier Science B.V. All rights reserved.